entertainment -WSS

entertainment

author：Wikipedia 2025-09-03 03:36:57 - browse：46

Mayo Clinic, in Rochester, Minnesota on — Photo by KEREM YUCEL/AFP via Getty Images

SAN FRANCISCO — Mayo Clinic has signed Silicon Valley tech startup Cerebras as its first generative AI partner, the health system announced Monday.

The health system — known for its cutting-edge research and willingness to partner with tech companies — will give Cerebras millions of dollars to help build technology tools based on Mayo’s trove of de-identified patient data, leaders announced at the J.P. Morgan Healthcare Conference. Mayo and Cerebras did not disclose the dollar amount, but Cerebras said it was a multimillion, multi-year contract.

With roughly 380 employees, Cerebras builds and sells supercomputers specifically designed for AI applications across several industries — pitting the upstart in direct competition with the market leader Nvidia Corp. Life sciences giants including GSK have used its technology for drug discovery, and it has partnered with a health network in United Arab Emirates, but this is Cerebras’ first AI contract with a U.S. health system. The deal gives Mayo access to Cerebras’ supercomputers as well as a Cerebras team to help develop health-tuned models; Mayo will then own whatever they build.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Alkermes shareholders re
Next article： Eli Lilly expects to double planned employment in Boston center

WSS

Lawmakers consider Medicare pay reforms for doctors

'The boss' wants server deleted: New allegations emerge in Trump indictment

FDA struggles to regulate food additives, sometimes for decades

Timeline: Special counsel's probe into Trump's handling of classified documents

Interest rates are at a 22

STAT Readout Newsletter: Today's biggest biotech updates

knowledge

entertainment

focus

New air purifier tech could be key to improving indoor air quality

Beam Therapeutics to lay off 20% of its staff, re

Psychedelics group wrestles with new pharma identity

FDA gives detailed accounting of AI

After affirmative action ruling, medical educators look to 'holistic review'

Lawmakers consider Medicare pay reforms for doctors

Novavax promises a turnaround & Lilly roils the obesity market

Bryan Kohberger seeks indictment dismissal in Idaho college killings case

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Ford recalls 870K F

focus

The explosion of genetic testing requires a new approach

Moscow blames Kyiv for missile attacks in southern Russia as Kremlin forces pound Ukrainian village

Biden announces an advanced cancer research initiative

2023 STAT Wunderkinds: get to know the winners

Will Ozempic

Why health workers in Gaza are injured or die at high rates

leisure time

focus

Wikipedia

knowledge